E. Ostermann

In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab.

W. Wadsak, M. Mitterhauser, A. Farkouh, 2006, Anticancer Research.

Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer.

J. Schueller, M. Czejka, E. Ostermann, 2005, Anticancer research.

Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab

Mansoor M Ahmed, J. Schueller, M. Czejka, 2013 .

Disposition of paclitaxel (Taxol®) and its metabolites in patients with advanced breast cancer (ABC) when combined with trastuzumab (Hercpetin®)

J. Schueller, M. Czejka, E. Ostermann, 2005, European Journal of Drug Metabolism and Pharmacokinetics.

Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorder

J. Finsterer, C. Stöllberger, G. Zuntner, 2009, Blood pressure.

Pharmacokinetics of Gemcitabine Combined with Trastuzumab in Patients with Advanced Breast Cancer

J. Schueller, M. Czejka, E. Ostermann, 2005, Oncology Research and Treatment.